2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund Palo Santo
09 mars 2023 10h19 HE
|
Palo Santo
CHICAGO and NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- As therapeutic applications of psychedelics gain more traction in the mainstream consciousness, psychedelics are a major focus at SXSW 2023,...
Palo Santo Closes $50 Million Psychedelic Therapeutics Investment Fund
12 oct. 2022 11h51 HE
|
Palo Santo
CHICAGO and NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, announced the closing of its...
Psychedelic Healthcare VC Fund Palo Santo to Participate as Panelists at SXSW Conference
24 févr. 2022 10h54 HE
|
Palo Santo
CHICAGO and NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Palo Santo, a leading psychedelic healthcare investment fund, will participate in two of the six panels devoted to psychedelic medicine in...
Psychedelic Healthcare VC Fund Palo Santo Appoints Zach Lomis as Partner
02 févr. 2022 08h00 HE
|
Palo Santo
CHICAGO and NEW YORK, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Palo Santo, a leading psychedelic healthcare investment fund, announced the appointment of Zach Lomis as partner. As part of Palo Santo’s...
U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Appoints New Members to Its Advisory Board, Amid Rapid Growth in Psychedelic Sector
08 nov. 2021 08h37 HE
|
Palo Santo
CHICAGO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Palo Santo, the leading U.S.–based psychedelic investment fund, announced its advisory board, which includes some of the world’s foremost leaders in their...
U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Announces Recent Investment in neurocare Group
21 sept. 2021 08h51 HE
|
Palo Santo
CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Palo Santo, a U.S.-based psychedelic investment fund, announced its recent investment in neurocare Group AG (“neurocare”), a leading provider of...